FDA Inspection 1303528 — Takeda Manufacturing Austria AG
The FDA completed an inspection of Takeda Manufacturing Austria AG on May 18, 2026 in Orth An Der Donau. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 18, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Orth An Der Donau (Austria)